Education
About Us
Working with TipRanks
Follow Us
Windlas Biotech Ltd. (IN:WINDLAS)
:WINDLAS
Total Valuation
Windlas Biotech Ltd. has a market cap or net worth of ₹18.58B. The enterprise value is ₹4.89B.
Market Cap₹18.58B
Enterprise Value₹4.89B
Share Statistics
Windlas Biotech Ltd. has 21,018,955 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,018,955
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Windlas Biotech Ltd.’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.34%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)9.34%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover1.00
Inventory Turnover5.80
Valuation Ratios
The current PE Ratio of Windlas Biotech Ltd. is 0.00. Windlas Biotech Ltd.’s PEG ratio is 1.90.
PE Ratio0.00
PS Ratio0.00
PB Ratio1.21
Price to Fair Value0.00
Price to FCF-49.11
Price to Operating Cash Flow8.00
PEG Ratio1.90
Income Statement
In the last 12 months, Windlas Biotech Ltd. had revenue of 7.60B and earned 609.94M in profits. Earnings per share was 0.00.
Revenue7.60B
Gross Profit2.88B
Operating Income661.22M
Pretax Income797.58M
Net Income609.94M
EBITDA1.12B
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Windlas Biotech Ltd. pays an annual dividend of ₹5.5, resulting in a dividend yield of 0.62%
Dividend Per Share₹5.5
Dividend Yield0.62%
Payout Ratio18.84%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change23.79%
50-Day Moving Average958.84
200-Day Moving Average957.08
Relative Strength Index (RSI)37.01
Average Volume (3m)4.43K
Important Dates
Windlas Biotech Ltd. upcoming earnings date is Sep 3, 2025, TBA Not Confirmed.
Last Earnings DateMay 22, 2025
Next Earnings DateSep 3, 2025
Ex-Dividend DateSep 17, 2024
Financial Position
Windlas Biotech Ltd. as a current ratio of 2.11, with Debt / Equity ratio of 1.24%
Current Ratio2.11
Quick Ratio1.78
Debt to Market Cap0.00
Net Debt to EBITDA0.29
Interest Coverage Ratio15.09
Taxes
In the past 12 months, Windlas Biotech Ltd. has paid 187.64M in taxes.
Income Tax187.64M
Effective Tax Rate0.24
Enterprise Valuation
Windlas Biotech Ltd. EV to EBITDA ratio is 0.29, with an EV/FCF ratio of 2.01.
EV to Sales0.04
EV to EBITDA0.29
EV to Free Cash Flow2.01
EV to Operating Cash Flow0.47
Balance Sheet
Windlas Biotech Ltd. has ₹2.40B in cash and marketable securities with ₹325.97M in debt, giving a net cash position of -₹2.08B billion.
Cash & Marketable Securities₹2.40B
Total Debt₹325.97M
Net Cash-₹2.08B
Net Cash Per Share-₹98.82
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 36.57%, with operating margin of 8.70%, and net profit margin of 8.03%.
Gross Margin36.57%
Operating Margin8.70%
Pretax Margin10.50%
Net Profit Margin8.03%
EBITDA Margin14.76%
EBIT Margin11.07%
Analyst Forecast
The average price target for Windlas Biotech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―